Commercial Mortgage for Buying a Pharmacy Freehold

The situation

An independent pharmacy owner in the North West had operated their NHS dispensing pharmacy from leased premises for nine years. The building's landlord, a private investor approaching retirement, decided to sell. The pharmacy owner was offered the freehold at £914,000 before it went to open market.

Losing the premises to another buyer would have been a serious problem. The pharmacy held an NHS dispensing contract tied to that location. Relocating would require a new contract application, an NHS England approval process, and a period of significant uncertainty for a business that dispensed an average of 14,000 items per month. The pharmacy owner's view was clear: owning the building was both commercially sensible and practically essential to the long-term stability of the business.

With a deposit of £274,000 available, the loan requirement was £640,000 at 70% LTV. The challenge was not the numbers. It was finding a lender who understood what a pharmacy freehold is and how to value and assess it correctly.

The complications

Pharmacy premises sit in an unusual part of the commercial property market. The bricks-and-mortar value of a ground-floor high street or parade unit may be modest. But a unit with a live NHS dispensing contract and an established patient medication record database has a trading value that materially exceeds the building's standalone worth. The correct valuation approach combines both. A standard commercial surveyor unfamiliar with pharmacy valuations will undervalue the premises, which in turn reduces the LTV available and can make the loan structure unworkable.

The NHS dispensing income model also presents challenges for generalist lenders. Income per item dispensed is set by NHS England under the Drug Tariff. It is not negotiable and not subject to market forces in the way that retail or hospitality income is. For a lender who understands the model, that predictability is a credit strength. For one who does not, it looks like dependency on a single contract.

There was also a valuation complexity specific to this property. The unit had been subject to a planning modification several years earlier that affected its permitted use classification. The pharmacy had operated lawfully throughout, but the planning history required careful review by the lender's surveyor and solicitors to confirm there was no residual risk to the security. This added time to the legal process and required a lender whose underwriting team would engage with the detail rather than decline on the basis of an imperfect planning history.

How we structured it

We identified a specialist commercial lender with a healthcare lending division and a panel of surveyors experienced in pharmacy valuations. The valuation came in at a figure that properly reflected both the building and the trading value of an established NHS dispensing pharmacy with a 14,000-item monthly volume. The LTV of 70% was calculated against this figure, not a bricks-and-mortar-only assessment that would have undervalued the security.

We presented the application with a full breakdown of the dispensing income: monthly NHS payment schedules for the previous 24 months, the Drug Tariff income by category, the Medicines Use Review and New Medicine Service income, and the OTC retail margin. The lender's healthcare credit team assessed the total income correctly, applying the DSCR test to the full pharmacy revenue picture rather than limiting their analysis to dispensing fees alone.

The planning history was addressed proactively. We instructed a planning consultant to produce a brief note confirming the current lawful use and the absence of any enforcement risk. This was included in the application pack from day one, removing what would otherwise have become a legal enquiry that could have delayed completion by several weeks.

A pharmacy with an NHS dispensing contract has predictable, contractually backed income. That is exactly what commercial lenders want to see. The challenge is finding a lender who knows how to read it.

The outcome

The £640,000 commercial mortgage completed on time. The pharmacy owner purchased the freehold of their premises at 70% LTV on a 15-year capital repayment basis, eliminating a lease that had been costing them £42,000 per year in rent. The monthly mortgage repayment is materially lower than the former rent, improving the pharmacy's operating cash position from month one.

The NHS contract, which would have been at risk during any relocation process, is now secured on a permanent basis within owned premises. The pharmacy owner has since begun exploring a minor extension to the dispensary to accommodate increased Medicines Use Review capacity, a project that would have required the landlord's consent under the previous lease arrangement.

What this demonstrates

Independent pharmacy owners purchasing their premises sit in a specialist but well-defined segment of the commercial mortgage market. The NHS contract income, pharmacy-specific valuation methodology, and owner-occupier structure all require a lender with genuine healthcare lending expertise. The majority of commercial lenders do not have this, which is why pharmacy freehold purchases often get declined at the first port of call.

The planning complexity in this case illustrates how proactive application management can prevent delays. A legal issue that arrives as a surprise during underwriting can add weeks to the process and, in some cases, cause a lender to withdraw. Identifying it in advance and resolving it before the application lands removes that risk entirely.

FD Commercial arranges owner-occupier commercial mortgages for pharmacy owners and healthcare professionals from £250,000. We work with lenders who understand NHS dispensing income, pharmacy valuations, and the specific legal considerations that arise in healthcare premises transactions. Call us on 03300 100315 or contact us here.